Lisa Gallicchio, Ph.D.
Program Director, Clinical and Translational Epidemiology Branch, Epidemiology and Genomics Research Program

Contact Information

Address:
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
9609 Medical Center Drive, Rm. 4E574, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)

Interest Areas

  • Cancer survivorship
  • Cancer treatment toxicity and long-term health of cancer survivors
  • Patient reported outcomes
  • Health disparities
  • Medication adherence
  • Women's health

Degrees

  • Ph.D. - Epidemiology
    University of Maryland at Baltimore, Department of Epidemiology and Public Health
  • M.S. - Epidemiology
    University of Maryland at Baltimore, Department of Epidemiology and Public Health

Biography

Dr. Lisa Gallicchio is a Program Director in the Epidemiology and Genomics Research Program's (EGRP) Clinical and Translational Epidemiology Branch (CTEB). She is responsible for managing a research portfolio of grants focused on clinical, lifestyle, and genomic factors that affect outcomes among cancer survivors, including those factors that may contribute to observed disparities in health outcomes. Dr. Gallicchio, along with Dr. Paige Green of the Behavioral Research Program, is leading the “Cancer and Accelerated Aging: Research for Healthier Survivors” initiative, which is focused on better understanding the effects that a cancer diagnosis and its treatment have on aging trajectories. Dr. Gallicchio’s other interests include post-diagnosis rare cancer outcomes and survivorship, the occurrence and effects of sleep disturbance and circadian rhythm disruption among cancer patients and survivors, and the application of epidemiologic methods to studying post-diagnosis cancer outcomes.

Prior to joining EGRP, Dr. Gallicchio was a Senior Epidemiologist in The Prevention and Research Center in the Weinberg Center for Women's Health & Medicine at Mercy Medical Center. During this time, she also served as an Adjunct Assistant Professor in the University of Maryland at Baltimore, Department of Epidemiology and Public Health and the Johns Hopkins University Bloomberg School of Public Health Department of Epidemiology. She was the Principal Investigator of a cohort study examining racial differences in the cardiovascular health effects of aromatase inhibitors, a hormonal therapy commonly used among breast cancer patients.

Select Publications

See listings of articles and other publications authored by Dr. Gallicchio inĀ PubMed.

Return to Top